These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19925414)

  • 1. Intra- and interdomain flexibility in matrix metalloproteinases: functional aspects and drug design.
    Bertini I; Fragai M; Luchinat C
    Curr Pharm Des; 2009; 15(31):3592-605. PubMed ID: 19925414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural studies of matrix metalloproteinases.
    Borkakoti N
    J Mol Med (Berl); 2000; 78(5):261-8. PubMed ID: 10954198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.
    Maskos K; Bode W
    Mol Biotechnol; 2003 Nov; 25(3):241-66. PubMed ID: 14668538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fell-Muir Lecture: Metalloproteinases: from demolition squad to master regulators.
    Murphy G
    Int J Exp Pathol; 2010 Aug; 91(4):303-13. PubMed ID: 20666850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The design, structure, and clinical update of small molecular weight matrix metalloproteinase inhibitors.
    Skiles JW; Gonnella NC; Jeng AY
    Curr Med Chem; 2004 Nov; 11(22):2911-77. PubMed ID: 15544483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quest for selectivity in inhibition of matrix metalloproteinases.
    Brown S; Meroueh SO; Fridman R; Mobashery S
    Curr Top Med Chem; 2004; 4(12):1227-38. PubMed ID: 15320723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
    Bode W; Maskos K
    Biol Chem; 2003 Jun; 384(6):863-72. PubMed ID: 12887053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in the development of matrix metalloproteinase inhibitors.
    Tu G; Xu W; Huang H; Li S
    Curr Med Chem; 2008; 15(14):1388-95. PubMed ID: 18537616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloprotease inhibitors: design from structure.
    Borkakoti N
    Biochem Soc Trans; 2004 Feb; 32(Pt 1):17-20. PubMed ID: 14748704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis of matrix metalloproteinase function.
    Bode W
    Biochem Soc Symp; 2003; (70):1-14. PubMed ID: 14587278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The design, structure, and therapeutic application of matrix metalloproteinase inhibitors.
    Skiles JW; Gonnella NC; Jeng AY
    Curr Med Chem; 2001 Mar; 8(4):425-74. PubMed ID: 11172697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M; Udi Y; Solomonov I; Sagi I
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of self-immolative linkers in the design of hydrogen peroxide activated metalloprotein inhibitors.
    Jourden JL; Daniel KB; Cohen SM
    Chem Commun (Camb); 2011 Jul; 47(28):7968-70. PubMed ID: 21677985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in the design of specific Matrix Metalloproteinase inhibitors aided by structural and computational studies.
    Rao BG
    Curr Pharm Des; 2005; 11(3):295-322. PubMed ID: 15723627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional bases for allosteric control of MMP activities: can it pave the path for selective inhibition?
    Sela-Passwell N; Rosenblum G; Shoham T; Sagi I
    Biochim Biophys Acta; 2010 Jan; 1803(1):29-38. PubMed ID: 19406173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase inhibitors: specificity of binding and structure-activity relationships.
    Gupta SP
    Exp Suppl; 2012; 103():v-vi. PubMed ID: 22642187
    [No Abstract]   [Full Text] [Related]  

  • 17. Matrix metalloproteinases.
    Fridman R
    Biochim Biophys Acta; 2010 Jan; 1803(1):1-2. PubMed ID: 20159302
    [No Abstract]   [Full Text] [Related]  

  • 18. Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs.
    Cuniasse P; Devel L; Makaritis A; Beau F; Georgiadis D; Matziari M; Yiotakis A; Dive V
    Biochimie; 2005; 87(3-4):393-402. PubMed ID: 15781327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural bases for substrate and inhibitor recognition by matrix metalloproteinases.
    Aureli L; Gioia M; Cerbara I; Monaco S; Fasciglione GF; Marini S; Ascenzi P; Topai A; Coletta M
    Curr Med Chem; 2008; 15(22):2192-222. PubMed ID: 18781944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Snapshots of the reaction mechanism of matrix metalloproteinases.
    Bertini I; Calderone V; Fragai M; Luchinat C; Maletta M; Yeo KJ
    Angew Chem Int Ed Engl; 2006 Dec; 45(47):7952-5. PubMed ID: 17096442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.